insights_auto
Sebab 2269 menurun 2.21%?
Terokai Dengan Lebih Terperincichevron_right
2269:HKG
WuXi Biologics (Cayman) Inc
HK$48.64
arrow_downward
-2.21%(-1.10) 1H
15 Okt, 4:08:33 PTG GMT+8 · HKD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk 2269...
Buka
HK$49.12
Tinggi
HK$50.30
Rendah
HK$48.36
Permodalan Pasaran
200.24B
Purata volum
29.86J
Volum
40.21J
Nisbah H/P
34.80
tgi 52 mgu
HK$58.00
rdh 52 mgu
HK$28.48
EPS
HK$1.40
Syer tertunggak
1.23B
Bilangan pekerja
15K
Buka
HK$49.12
Tinggi
HK$50.30
Rendah
HK$48.36
Permodalan Pasaran
200.24B
Purata volum
29.86J
Volum
40.21J
Nisbah H/P
34.80
tgi 52 mgu
HK$58.00
rdh 52 mgu
HK$28.48
EPS
HK$1.40
Syer tertunggak
1.23B
Bilangan pekerja
15K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Astro Awani
·
10 jam lalu
S&P 500: Wall Street market update | 15 October 2026
Invezz
·
2 hari lalu
Dow Jones dibuka 190 mata lebih tinggi, pelabur memerhati pendapatan bank dan inflasi
Invezz
·
2 hari lalu
Dow naik 198 mata, saham AS bercampur menjelang keputusan pendapatan
Invezz
·
1 hari lalu
Dow ditutup 170 mata lebih rendah ketika penjualan saham cip berterusan
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Perihal WuXi Biologics (Cayman) Inc